Company

Rhythm Biotherapeutics Inc.

Biotechnology Research Ottawa, Ontario, Ca 6 employees

Employees: 6
Contacts: 1
Emails: 1

www.rthm.bio LinkedIn Crunchbase

Rhythm Biotherapeutics Inc. Overview

Headquarters: Ottawa, Ontario, Ca
Website: www.rthm.bio
Industry: Biotechnology Research
Employees: 6
Founded: 2022
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

About Rhythm Biotherapeutics Inc.

Rhythm Biotherapeutics Inc. (RBI) is a pre-clinical spinout of the University of Ottawa Heart Institute, founded in November 2022 by Darryl Davis, a cardiac electrophysiologist pioneering novel therapies to prevent and cure atrial fibrillation (AF). The company has developed a patent pending exosome therapy that, in animal studies, has proven to effectively prevent postoperative atrial fibrillation (POAF). RBI’s therapy uniquely addresses atrial inflammation and fibrosis, the fundamental physiological mechanism driving POAF. RBI is currently seeking investors who will accelerate achieving its next milestones. The obtainable market in North America and Europe for POAF therapy is over US$2B per year and growing.

Rhythm Biotherapeutics Inc. Contact Details

People in AeroLeads: 4
With contact data: 1
Email contacts: 1; 25.0% coverage

Rhythm Biotherapeutics Inc. Org Chart

Sample employees and titles

Name	Title	Location	Contact
Darryl Davis	Clinician Scientist at University	Ottawa, Ontario, Canada	View
Noreen Ahmed, Phd	Scientist Working on the Development	Canada	View
Stephen Fanjoy	Fcmc	Ottawa, Ontario, Canada	Email
Leah Mcmunn		Ottawa, Ontario, Canada	View